Centiva Capital’s Smith & Wesson SWBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$718K Sell
47,759
-4,860
-9% -$73K 0.01% 747
2026
Q1
$754K Buy
+52,619
New +$639K 0.01% 682
2024
Q2
Sell
-15,928
Closed -$277K 2488
2024
Q1
$277K Buy
+15,928
New +$230K 0.01% 1289
2023
Q2
Sell
-16,083
Closed -$198K 1980
2023
Q1
$198K Buy
+16,083
New +$172K ﹤0.01% 1243
2021
Q4
Sell
-14,068
Closed -$291K 1526
2021
Q3
$291K Sell
14,068
-6,726
-32% -$162K 0.02% 796
2021
Q2
$721K Sell
20,794
-9,095
-30% -$190K 0.02% 698
2021
Q1
$522K Buy
29,889
+6,489
+28% +$118K 0.02% 548
2020
Q4
$415K Buy
23,400
+10,619
+83% +$176K 0.02% 518
2020
Q3
$198K Sell
12,781
-1,155
-8% -$20.4K 0.01% 606
2020
Q2
$231K Buy
+13,936
New +$129K 0.01% 478

Other funds holding SWBI

Centiva Capital's SWBI Position: Q2 2026 in Review

Centiva Capital reduced its Smith & Wesson (SWBI) stake by 9.2% in Q2 2026, selling an estimated $73K and leaving 47,759 shares worth $718K. The position accounts for 0.01% of the portfolio, ranked #747.

Centiva Capital first reported a position in SWBI in Q2 2020 and has held it in 10 quarters since. The position peaked at $754K in Q1 2026. 200 funds tracked by Wall St. Rank hold SWBI as of Q2 2026.

  • Centiva Capital held 47,759 shares of Smith & Wesson worth $718K as of Q2 2026.
  • Centiva Capital sold 4,860 Smith & Wesson shares in Q2 2026, an estimated $73K.
  • Smith & Wesson made up 0.01% of Centiva Capital's portfolio in Q2 2026, its #747 holding.
  • Centiva Capital first reported a position in Smith & Wesson in Q2 2020 and has held it in 10 quarters since.
  • Centiva Capital's Smith & Wesson position peaked at $754K in Q1 2026.
  • 200 funds tracked by Wall St. Rank held Smith & Wesson as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.